ATRT RECURRENT
Clinical trials for ATRT RECURRENT explained in plain language.
Never miss a new study
Get alerted when new ATRT RECURRENT trials appear
Sign up with your email to follow new studies for ATRT RECURRENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for kids with brain cancer: triple therapy trial launches
Disease control Recruiting nowThis early-phase study tests a new drug (SGT-53) combined with radiation and immunotherapy (Nivolumab) for children whose brain tumors have returned or not responded to standard treatments. The goal is to find a safe dose and understand side effects. Up to 18 children with specif…
Matched conditions: ATRT RECURRENT
Phase: EARLY_PHASE1 • Sponsor: Children's National Research Institute • Aim: Disease control
Last updated May 26, 2026 08:41 UTC
-
New hope for kids with recurring brain tumors: low-dose combo therapy aims to buy time
Disease control Recruiting nowThis study tests a combination of low-dose chemotherapy and targeted drugs to slow tumor growth in children whose brain cancers have returned. The goal is to extend survival while maintaining a good quality of life. About 232 children with recurrent medulloblastoma, ependymoma, A…
Matched conditions: ATRT RECURRENT
Phase: PHASE2 • Sponsor: Medical University of Vienna • Aim: Disease control
Last updated May 26, 2026 08:37 UTC